These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24690767)

  • 1. New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases.
    Fagyas M; Úri K; Siket IM; Daragó A; Boczán J; Bányai E; Édes I; Papp Z; Tóth A
    PLoS One; 2014; 9(4):e93719. PubMed ID: 24690767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.
    Fagyas M; Úri K; Siket IM; Daragó A; Boczán J; Bányai E; Édes I; Papp Z; Tóth A
    PLoS One; 2014; 9(4):e87843. PubMed ID: 24691160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New perspectives in the renin-angiotensin-aldosterone system (RAAS) II: albumin suppresses angiotensin converting enzyme (ACE) activity in human.
    Fagyas M; Úri K; Siket IM; Fülöp GÁ; Csató V; Daragó A; Boczán J; Bányai E; Szentkirályi IE; Maros TM; Szerafin T; Édes I; Papp Z; Tóth A
    PLoS One; 2014; 9(4):e87844. PubMed ID: 24691203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pressor and hormonal responses to angiotensin I infusion in healthy subjects of different angiotensin-converting enzyme genotypes.
    Chadwick IG; O'Toole L; Morice AH; Yeo WW; Jackson PR; Ramsay LE
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):485-9. PubMed ID: 9156358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.
    Lee AF; MacFadyen RJ; Struthers AD
    Eur J Heart Fail; 1999 Dec; 1(4):401-6. PubMed ID: 10937954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism.
    Adin D; Atkins C; Domenig O; DeFrancesco T; Keene B; Tou S; Stern JA; Meurs KM
    J Vet Intern Med; 2020 Mar; 34(2):600-606. PubMed ID: 32112596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension].
    Khadartsev AA; Logatkina AV; Terekhov IV; Bondar SS; Bondar NV
    Ter Arkh; 2017; 89(12):97-102. PubMed ID: 29411767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype.
    Cicoira M; Zanolla L; Rossi A; Golia G; Franceschini L; Cabrini G; Bonizzato A; Graziani M; Anker SD; Coats AJ; Zardini P
    J Am Coll Cardiol; 2001 Jun; 37(7):1808-12. PubMed ID: 11401115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects.
    Lachurié ML; Azizi M; Guyene TT; Alhenc-Gelas F; Ménard J
    Circulation; 1995 Jun; 91(12):2933-42. PubMed ID: 7796503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentration of renin-angiotensin system components in association with ACE I/D polymorphism among hypertensive subjects in response to ACE inhibitor therapy.
    Hristova M; Stanilova S; Miteva L
    Clin Exp Hypertens; 2019; 41(7):662-669. PubMed ID: 30307755
    [No Abstract]   [Full Text] [Related]  

  • 12. Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease.
    Rudnicki M; Mayer G
    Pharmacogenomics; 2009 Mar; 10(3):463-76. PubMed ID: 19290794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of gene polymorphisms in the renin-angiotensin system to macroangiopathy in patients with diabetic nephropathy.
    Wong TY; Szeto CC; Chow KM; Chan JC; Li PK
    Am J Kidney Dis; 2001 Jul; 38(1):9-17. PubMed ID: 11431175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum angiotensin-converting enzyme 2 concentration and angiotensin-(1-7) concentration in patients with acute heart failure patients requiring emergency hospitalization.
    Hisatake S; Kiuchi S; Kabuki T; Oka T; Dobashi S; Ikeda T
    Heart Vessels; 2017 Mar; 32(3):303-308. PubMed ID: 27421979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity of renin-angiotensin-aldosterone system (RAAS) and vasopressin level in patients with primary pulmonary hypertension].
    Martyniuk TV; Chazova IE; Masenko VP; Volkov VN; Belenkov IuN
    Ter Arkh; 1998; 70(4):33-6. PubMed ID: 9612899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension.
    Pontremoli R; Ravera M; Viazzi F; Nicolella C; Berruti V; Leoncini G; Giacopelli F; Bezante GP; Sacchi G; Ravazzolo R; Deferrari G
    Kidney Int; 2000 Feb; 57(2):561-9. PubMed ID: 10652033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between ACE and AGT polymorphism and cardiovascular risk in acromegalic patients.
    Erbas T; Cinar N; Dagdelen S; Gedik A; Yorgun H; Canpolat U; Kabakci G; Alikasifoglu M
    Pituitary; 2017 Oct; 20(5):569-577. PubMed ID: 28712073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake.
    van der Kleij FGH; de Jong PE; Henning RH; de Zeeuw D; Navis G
    J Am Soc Nephrol; 2002 Apr; 13(4):1025-1033. PubMed ID: 11912262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Tissue Angiotensin Converting Enzyme (ACE) Activity Is Regulated by Genetic Polymorphisms, Posttranslational Modifications, Endogenous Inhibitors and Secretion in the Serum, Lungs and Heart.
    Bánhegyi V; Enyedi A; Fülöp GÁ; Oláh A; Siket IM; Váradi C; Bottyán K; Lódi M; Csongrádi A; Umar AJ; Fagyas M; Czuriga D; Édes I; Pólos M; Merkely B; Csanádi Z; Papp Z; Szabó G; Radovits T; Takács I; Tóth A
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.